Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Harvard Business School
Moodys
McKinsey
Merck

Last Updated: November 13, 2019

DrugPatentWatch Biologics Dashboard

Your Other Dashboards:

Small Molecule Drugs Drug Price Drug Sales Litigation Drugs in Development Bulk Data Book: Make Better Decisions

Upgrade for More Features

Upgrade to a full subscription to unlock our entire dataset and to enjoy subscriber-only features.

Whether you need access for yourself or for your whole team, DrugPatentWatch offers subscription plans tailored to your needs. Attractive pricing is available for small groups or for enterprise-wide access.

For more information see the Plans and Pricing and Discount Schedule. Please contact us with any questions.

➤ See Plans and Pricing
Contact Sales

Popular Searches 

Ingredient
A  B  C  D  E  F  G  H  I  J  K  L  M  
N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

Search by ingredient:

Search
Tradename
A  B  C  D  E  F  G  H  I  J  K  L  M  
N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

Search by tradename:

Search
Recent Biosimilar Clinical Trials
drugnameSponsorStart Date
adalimumab Fundación Pública Andaluza para la gestión de la Investigación en Sevilla2019-10-01
eculizumab Samsung Bioepis Co., Ltd.2019-08-01
adalimumab Pieter Dewint, MD PhD2019-08-01

International Patent Information 

International Patents

Patents by country:

Search
Supplementary Protection Certificates

Supplementary Protection Certificiates by country:

Search

US Regulatory and Patent Information 

Biologic Drug Patent Expiration
2019   2020   2021   2022   2023   2024  
2025   2026   2027   2028   2029   2030  
2031   2032   2033   2034   2035   2036  
2037   2038   2039  

Search for patents expiring in year:

Search

Biologics License Application

Search by BLA number:

Search
Drug Master Files

Search by DMF holder / Company name:

Search

Search by DMF subject / Generic name:

Search

All Active DMFs >>

Applicant Name
A  B  C  D  E  F  G  H  I  J  K  L  M  
N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

Search by applicant name:

Search
Approval Date

Search for biologic drugs approved in:

Search

Pharmaceutical Class and Dosage 

Pharmacology

Search by pharmacology:

Ingredient

Drug Class

Mechanism of Action

Physiological Effect

Dosage
Search by dosage:
Search

Finished Product Suppliers 

Finished Product Suppliers

Search by tradename:

Search

Search by biologic ingredient:

Search

Upgrade for More Features

Upgrade to a full subscription to unlock our entire dataset and to enjoy subscriber-only features.

Whether you need access for yourself or for your whole team, DrugPatentWatch offers subscription plans tailored to your needs. Attractive pricing is available for small groups or for enterprise-wide access.

For more information see the Plans and Pricing and Discount Schedule. Please contact us with any questions.

➤ See Plans and Pricing
Contact Sales

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Baxter
Medtronic
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.